Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT) | |
Woo, H.; Fizaz, K.; Sulur, G.; Tran, N.; Fein, L.; Matsubara, N.; Rodriguez-Antolin, A.; Alekseev, B.; Ozguroglu, M.; Ye, D. | |
2019 | |
卷号 | 123 |
会议录 | BJU INTERNATIONAL |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 1464-4096 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3596845 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Woo, H.,Fizaz, K.,Sulur, G.,et al. Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论